l ‐2‐Hydroxyglutarate contributes to tumor radioresistance through regulating the hypoxia‐inducible factor‐1α signaling pathway
Journal of Cellular Physiology · 2024
DOI: 10.1002/jcp.31384 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular Physiology, 2024. Verfasst von Manman Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China. Hauptthemen laut MEDLINE: Hypoxia-Inducible Factor 1, alpha Subunit, Radiation Tolerance, Glutarates, Signal Transduction. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, CAMS Innovation Fund for Medical Science, Natural Science Foundation of Tianjin.
Abstract (Originalsprache)
l ‐2‐Hydroxyglutarate ( l ‐2‐HG) has been regarded as a tumor metabolite, and it plays a crucial role in adaptation of tumor cells to hypoxic conditions. However, the role of l ‐2‐HG in tumor radioresistance and the underlying mechanism have not yet been revealed. Here, we found that l ‐2‐HG exhibited to have radioresistance effect on U87 human glioblastoma cells, which could reduce DNA damage and apoptosis caused by irradiation, promote cell proliferation and migration, and impair G2/M phase arrest. Mechanistically, l ‐2‐HG upregulated the protein level of hypoxia‐inducible factor‐1α (HIF‐1α) and the expression levels of HIF‐1α downstream target genes. The knockdown of l ‐2‐hydroxyglutarate dehydrogenase ( L2HGDH ) gene promoted the tumor growth and proliferation of U87 cells in nude mice by increasing HIF‐1α expression level in vivo. In addition, the low expression level of L2HGDH gene was correlated with the short survival of patients with glioma or kidney cancer. In conclusion, our study revealed the role and mechanism of l ‐2‐HG in tumor radioresistance and may provide a new perspective for overcoming tumor radioresistance and broaden our comprehension of the role of metabolites in tumor microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
- Tianjin Key Laboratory of Radiation Medicine and Molecular Nuclear Medicine, Tianjin, China.
- Tianjin Institutes of Health Science, Tianjin, China.
- State Key Laboratory of Advanced Medical Materials and Devices, Tianjin, China.
Förderung
- National Natural Science Foundation of China
- CAMS Innovation Fund for Medical Science
- Natural Science Foundation of Tianjin
- CIRP Open Fund of Radiation Protection Laboratories
Zitieren
APA
Zhang, M., Liu, Y., Lu, X., Du, L., He, N., Song, H., Wang, J., Gu, Y., Yang, M., Xu, C., Wang, Y., Ji, K., & Liu, Q. (2024). l ‐2‐Hydroxyglutarate contributes to tumor radioresistance through regulating the hypoxia‐inducible factor‐1α signaling pathway. Journal of Cellular Physiology. https://doi.org/10.1002/jcp.31384
Vancouver
Zhang M, Liu Y, Lu X, Du L, He N, Song H, et al. l ‐2‐Hydroxyglutarate contributes to tumor radioresistance through regulating the hypoxia‐inducible factor‐1α signaling pathway. Journal of Cellular Physiology. 2024. doi:10.1002/jcp.31384
BibTeX
@article{Zhang2024,
author = {Zhang, Manman and Liu, Yingshuang and Lu, Xinran and Du, Liqing and He, Ningning and Song, Huijuan and Wang, Jinhan and Gu, Yeqing and Yang, Mengmeng and Xu, Chang and Wang, Yan and Ji, Kaihua and Liu, Qiang},
title = {l ‐2‐Hydroxyglutarate contributes to tumor radioresistance through regulating the hypoxia‐inducible factor‐1α signaling pathway},
journal = {Journal of Cellular Physiology},
year = {2024},
doi = {10.1002/jcp.31384}
}
EUVIMED